Navigating Pregnancy-Associated Cancer: Upcoming YO4YO Case Discussion with Ann Partridge and Matteo Lambertini

Complexities of pregnancy-Associated Cancer to be Discussed by Leading Oncologists

A forthcoming discussion will address the intricate clinical and ethical challenges presented by cancer diagnosed during pregnancy. The session, designed as an interactive case study, aims to provide insights for healthcare professionals navigating these arduous situations. Cancer during pregnancy, known as pregnancy-associated cancer, remains a rare but increasingly recognized area of oncological care.

What is Pregnancy-Associated Cancer?

Pregnancy-associated cancer encompasses any malignancy diagnosed during pregnancy, labour, or within six months of delivery. According to the American Cancer Society, while the overall incidence is low—estimated at about 1 in 1,000 pregnancies—the numbers are rising perhaps due to delayed childbearing. This period presents unique difficulties,needing careful weighing of treatment options for both the mother and developing fetus.

Unique Challenges in Treatment

Customary cancer treatments—such as chemotherapy and radiation—can pose important risks during pregnancy. The need to minimize fetal exposure to harmful agents while effectively fighting the cancer demands a highly specialized approach. Oncologists must consider gestational age, cancer type, and stage to craft a balanced plan. A 2023 study published in The Lancet Oncology highlighted the growing evidence supporting the feasibility of continuing certain cancer therapies during pregnancy, alongside close monitoring of the fetus.

Upcoming Expert Discussion

The virtual session, organized as part of the Young Oncologists Committee (YO4YO) series, is scheduled for February 9, 2026, from 14:00–15:00 Central European Time (CET). It will be led by leading experts in the field.

Expert	affiliation	Role
Guilherme Nader Marta	Dana-Farber Cancer Institute	Moderator
Ann Partridge	Undisclosed	Panelist
Matteo Lambertini	Undisclosed	Panelist

Guilherme Nader Marta, an Advanced Clinical Fellow at Dana-farber Cancer Institute, will guide the discussion. He will be joined by Ann partridge and Matteo Lambertini,both recognized specialists in oncology. The format will encourage participation, employing a case-based learning approach.

Ethical Considerations

Beyond clinical hurdles, pregnancy-associated cancer frequently evokes complex ethical dilemmas. These range from questions of informed consent and patient autonomy to the potential impact of treatment decisions on the child’s future health. The discussion aims to illuminate these sensitive areas, providing guidance for navigating uncertain terrain.Resources from the National Cancer Institute (https://www.cancer.gov/) provide further background on cancer and pregnancy.

What are the biggest obstacles you foresee in treating cancer during pregnancy? How can we better support patients and families facing this challenging diagnosis?

Share this article with yoru network and join the conversation below!

What topics will be covered in the YO4YO case discussion on pregnancy‑associated cancer?

Navigating Pregnancy-Associated Cancer: Upcoming YO4YO Case Discussion with Ann Partridge and Matteo Lambertini

Pregnancy-associated cancer (PAC), encompassing cancers diagnosed during pregnancy or within a year postpartum, presents a unique and complex challenge for both patients and oncologists.The interplay between maternal physiology, fetal progress, and cancer treatment necessitates a highly individualized approach. An upcoming YO4YO case discussion featuring leading experts Ann Partridge and Matteo Lambertini promises to delve into the nuances of managing these difficult cases. This article outlines key considerations and previews the insights expected from this vital discussion,focusing on optimal treatment strategies and supportive care for women facing a cancer diagnosis during or after pregnancy.

Understanding the Scope of Pregnancy-Associated Cancer

PAC is relatively rare, accounting for approximately 1 in 1,000 pregnancies. However, its incidence is rising, potentially due to delayed childbearing. The types of cancer most commonly associated with pregnancy include:

* Breast Cancer: The most frequent PAC, frequently enough diagnosed during the second or third trimester. Hormone receptor status and HER2 expression are crucial for treatment planning.

* Cervical cancer: Often detected through routine prenatal screening, requiring careful staging and consideration of fetal safety.

* Melanoma: Can be aggressive during pregnancy, demanding prompt diagnosis and treatment.

* Hematologic Malignancies: Including leukemia and lymphoma, these cancers require specialized management due to thier systemic nature.

* gestational Trophoblastic Disease (GTD): While technically not cancer,GTD requires similar management principles and is often discussed alongside PAC.

The Challenges of treatment During Pregnancy

Treating cancer during pregnancy requires a delicate balance. The primary goals are to ensure the best possible outcome for both mother and baby.This often involves multidisciplinary collaboration between medical oncologists, maternal-fetal medicine specialists, surgeons, and radiation oncologists.

Key considerations include:

1. Fetal Safety: Many chemotherapy agents and radiation therapies can have teratogenic effects, meaning they can cause birth defects. Careful selection of treatment modalities and timing is essential.
2. maternal Physiology: Pregnancy alters drug metabolism and organ function, impacting treatment efficacy and toxicity.
3. Diagnostic Delays: Symptoms of cancer can sometimes be attributed to pregnancy, leading to delayed diagnosis.
4. Psychological Impact: A cancer diagnosis during pregnancy is emotionally devastating, requiring comprehensive psychosocial support.

treatment Options & Considerations by Cancer Type

The optimal treatment approach varies depending on the cancer type,stage,and gestational age.

* Breast Cancer: Neoadjuvant chemotherapy (chemotherapy before surgery) is frequently enough favored to allow for fetal maturation. Surgery is typically delayed until after delivery. Hormone therapy is generally avoided during pregnancy.

* Cervical Cancer: Treatment depends on the stage. Early-stage disease may be managed with radical trachelectomy (removal of the cervix) to preserve fertility. More advanced stages require chemoradiation,frequently enough delivered postpartum.

* Melanoma: Surgical excision is the primary treatment. Interferon therapy may be considered postpartum.

* Hematologic Malignancies: Treatment is complex and frequently enough involves chemotherapy regimens with lower fetal toxicity profiles.

The Role of YO4YO and the Upcoming Case Discussion

YO4YO (Young onset for Young Oncology) is a valuable platform for discussing challenging cases in young adults with cancer. The upcoming case discussion with Ann Partridge (Massachusetts General Hospital) and Matteo Lambertini (IRCCS Istituto romagna for the Study of Cancer) will focus on a real-world case of PAC, providing practical insights into:

* Treatment Sequencing: Determining the optimal order of treatments to maximize maternal and fetal outcomes.

* Novel Therapies: Exploring the role of newer targeted therapies and immunotherapies in PAC.

* Fertility Preservation: Discussing options for preserving fertility in women diagnosed with cancer during or after pregnancy.

* Long-Term Follow-Up: Addressing the unique long-term surveillance needs of women treated for PAC.

Benefits of a Multidisciplinary Approach

A collaborative, multidisciplinary approach is paramount in PAC management. Benefits include:

* Improved Diagnostic accuracy: Early and accurate diagnosis is crucial for optimal treatment.

* Personalized Treatment Plans: Tailoring treatment to the individual patient’s needs and circumstances.

* Enhanced Supportive Care: Addressing the physical, emotional, and psychological needs of both mother and baby.

* Optimized Outcomes: Improving both maternal survival and fetal health.

Practical Tips for Healthcare Professionals

* Maintain a High Index of Suspicion: Be vigilant for cancer symptoms in pregnant and postpartum women.

* Utilize Non-Invasive Diagnostic Techniques: Prioritize imaging modalities with minimal fetal radiation exposure.

* consult with Specialists: Seek expert guidance from medical oncologists, maternal-fetal medicine specialists, and other relevant disciplines.

* Provide Comprehensive Counseling: educate patients about the risks and benefits of treatment options.

Resources for Patients and Families

* National Cancer Institute (NCI): https://www.cancer.gov/

* American Cancer Society (ACS): https://www.cancer.org/

* Pregnancy-Associated Cancer resource Center: (search online for current resources as websites change)

* YO4YO: